Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UK grocery sales growth hits 10-month low, says Kantar

(Sharecast News) - Annual sales growth at UK grocery stores slowed to its lowest rate in 10 months in March, according to data out on Tuesday from research firm Kantar, as promotional activity picked up. Take-home sales across the grocery sector rose by just 1.8% over the four weeks to 23 March when compared with last year, compared with 3.6% growth seen the previous month.

Over the period, grocery price inflation rose to 3.5%, up from 3.3% in February.

Retailers' price cuts were responsible for £2.6bn of promotional spending, which was 8.8% more than the same time last year, Kantar data showed, while £686m was spent on multibuy deals and 'extra free' offers.

"With prices continuing to rise, supermarkets are mindful of the need to invest to attract shoppers through their doors," said Fraser McKevitt, head of retail and consumer insight at Kantar.

"Promotional sales ramped up this month to 28.2% of total grocery spending, the highest level we've seen in March for four years."

For the three months to 23 March, market leader Tesco booked £9.68bn of sales, up 5.4% on the year before, taking its market share to 27.9% from 27.3%.

Sainsbury also saw sales rise 4.1% year-on-year to £5.29bn, while Asda recorded a 5.6% drop to £4.33bn, taking their market shares to 15.2% and 12.5%, respectively.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.